Валацикловир в терапии опоясывающего герпеса: возможности и перспективы

________________________________________________

1. Purifoy DJ, Beauchamp LM, de Miranda P et al. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus. J Med Virol 1993; Suppl. 1: 139–45.
2. Weller S, Blum MR, Doucette M et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993; 54 (6): 595–605.
3. Jacobson MA. Valaciclovir (BW256U87): the L-valyl ester of acyclovir. J Med Virol 1993; (Suppl. 1): 150–3.
4. Darby G. Acyclovir – and beyond. J Int Med Res 1994; 22 (Suppl. 1): 33A–42A.
5. Gnann JW. New antivirals with activity against varicella-zoster virus. Ann Neurol 1994; 35 (Suppl.): S69–72.
6. Perry CM, Faulds D. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs 1996; 52 (5): 754–72.
7. Shinkai I, Ohta Y. New drugs – reports of new drugs recently approved by the FDA. Valacyclovir. Bioorg Med Chem 1996; 4 (1): 1–2.
8. Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995; 28 (4): 281–90.
9. Reusser P. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996; 33 (4): 235–48.
10. Acosta EP, Fletcher CV. Valacyclovir. Ann Pharmacother 1997; 31 (2): 185–91.
11. Piérard GE, Nikkels AF. Drug of the month. Valaciclovir (Zelitrex). Rev Med Liege 1997; 52 (8): 553–5.
12. Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review. Indian J Dermatol Venereol Leprol 2018; 84 (3): 251–62.
13. Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(RR-5): 1–30.
14. Федеральные клинические рекомендации. Дерматовенерология 2015. Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016. / Federalnye klinicheskie rekomendacii. Dermatovenerologiya 2015. Bolezni kozhi. Infekcii, peredavaemye polovym putem. 5-e izd., pererab. i dop. M.: Delovoj ekspress, 2016. [in Russian]
15. Bruxelle J, Pinchinat S. Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: review of international publications. Med Mal Infect 2012; 42 (2): 53–8.
16. Fukushima T, Sato T, Nakamura T et al. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib. Anticancer Res 2012; 32 (12): 5437–40.
17. Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention. Med Klin (Munich) 2010; 105 (6): 399–403.
18. Kimberlin DW, Jacobs RF, Weller S et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis 2010; 50 (2): 221–8.
19. Ono F, Yasumoto S, Furumura M et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster. J Dermatol 2012; 39 (11): 902–8.
20. McDonald EM, de Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther 2012; 17 (2): 255–64.
21. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304 (8): 859–66.
22. Pavan-Langston D. Herpes zoster antivirals and pain management. Ophthalmology 2008; 115 (Suppl. 2): S13–20.
23. Smith DE, Gold J. Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity. Sex Health 2007; 4 (2): 141–2.
24. Jubelt B. Valacyclovir and famciclovir therapy in herpes zoster. Curr Neurol Neurosci Rep 2002; 2 (6): 477–8.
25. Dworkin RH, Johnson RW, Breuer J et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44 (Suppl. 1): S1–26.

________________________________________________

M.V.Zhuchkov*1,2, E.E.Bolshakova1, D.B.Sonin1, S.A.Rodionova1
1. Ryazan State Regional Dermato-Venerological Clinic. 
390046, Russian Federation, Ryazan, ul. Sportivnaia, d. 9;
2. I.P.Pavlov Ryazan State Medical University of the Ministry of Health of the Russian Federation. 390026, Russian Federation, Riazan, ul. Vysokovol'tnaia, d. 9
*misha.juchkov@gmail.com